TY - JOUR
T1 - Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity
T2 - A Review of the Literature
AU - Goldfarb, Neil I.
AU - Weston, Christine
AU - Hartmann, Christine W.
AU - Sikirica, Mirko
AU - Crawford, Albert
AU - He, Hope
AU - Howell, Jamie
AU - Maio, Vittorio
AU - Clarke, Janice
AU - Nuthulaganti, Bhaskar
AU - Cobb, Nicole
PY - 2004/3
Y1 - 2004/3
N2 - This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions-asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a corner-stone of disease management.
AB - This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions-asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a corner-stone of disease management.
UR - http://www.scopus.com/inward/record.url?scp=12144288551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12144288551&partnerID=8YFLogxK
U2 - 10.1089/109350704322919005
DO - 10.1089/109350704322919005
M3 - Review article
C2 - 15035834
AN - SCOPUS:12144288551
SN - 1093-507X
VL - 7
SP - 61
EP - 75
JO - Disease Management
JF - Disease Management
IS - 1
ER -